Investor Presentaiton

Consistent Performance on yearly basis Operating Revenue (cr.) Gross Profit (* cr.) & Gross Profit Margin % EBITDA (cr.) & EBITDA Margin % 1046.0 9MFY21 1072.8 9MFY22 ©2021 - Marksans Pharma Limited, All Rights Reserved. 601.3 567.6 244.2 195.2 57.5% 23.3% 52.9% PAT ( cr.) & PAT Margin 159.0 157.2 15.2% 14.3% 18.2% 9MFY21 9MFY22 9MFY21 9MFY22 9MFY21 9MFY22 7

View entire presentation